NovaQuest BioPharma manages product and company-related investments in the global healthcare industry. Our primary focus is product-based investments in late-stage clinical and commercial BioPharma programs. The BioPharma team has worked together since 2000 and brings over 100 years of collective deal-making experience. Our strategy and investments are customized to meet the structural, accounting, and governance needs of our partners and to provide material co-funding to the industry.

Investment Criteria

NovaQuest BioPharma invests together alongside with global BioPharma companies in their most core, highly strategically important product programs, ensuring alignment with our partners.

  • Clinical and commercial program with compelling data and material NPVs
  • R&D and/or SG&A co-investment to align BioPharma companies and NovaQuest interests
  • Single-asset and multiple-asset NovaQuest investments
  • Material but right-sized NovaQuest investment (up to $250m+)
  • Flexible and customized structures to meet BioPharma companies financial and accounting needs
  • BioPharma companies retain program’s strategic and operational control
  • Simplified investment governance and contracting
  • NovaQuest investment across all Therapeutic Areas
  • NovaQuest provides Development and commercial operations expertise and services.



Company Therapy Area Stage
Cardiovascular Phase III
Hematology Phase III
Not Disclosed Not Disclosed
Not Disclosed Commercial
Not Disclosed Phase III
GI/Other Phase III
Respiratory Commercial/Phase III
Hematology Phase III
Urology Commercial
Oncology Commercial
Oncology Phase II
Neurology Phase III